Stephen Adamu

1.3k total citations
22 papers, 1.0k citations indexed

About

Stephen Adamu is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Stephen Adamu has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Ophthalmology and 6 papers in Oncology. Recurrent topics in Stephen Adamu's work include Ocular Infections and Treatments (7 papers), Bone Metabolism and Diseases (7 papers) and Bone health and treatments (6 papers). Stephen Adamu is often cited by papers focused on Ocular Infections and Treatments (7 papers), Bone Metabolism and Diseases (7 papers) and Bone health and treatments (6 papers). Stephen Adamu collaborates with scholars based in United States, Russia and Austria. Stephen Adamu's co-authors include Paul J. Kostenuik, Sean Morony, David L. Lacey, Frank Asuncion, Bartly J. Mondino, Colin R. Dunstan, Zhaopo Geng, Mario Grisanti, Brad Bolon and Casey Capparelli and has published in prestigious journals such as Endocrinology, Infection and Immunity and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Stephen Adamu

22 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Adamu United States 15 635 464 289 155 118 22 1.0k
Yuji Nakamachi Japan 16 553 0.9× 104 0.2× 31 0.1× 24 0.2× 160 1.4× 49 1.1k
Kees A. Hoeben Netherlands 14 374 0.6× 257 0.6× 46 0.2× 8 0.1× 123 1.0× 17 804
Anne Gallois France 13 219 0.3× 402 0.9× 35 0.1× 184 1.2× 47 0.4× 22 1.1k
Yoshinari Myoken Japan 17 391 0.6× 151 0.3× 40 0.1× 10 0.1× 55 0.5× 53 925
Laura García‐García Spain 18 262 0.4× 111 0.2× 17 0.1× 84 0.5× 23 0.2× 38 812
Giovanna D’Agosto Italy 16 215 0.3× 242 0.5× 48 0.2× 12 0.1× 279 2.4× 34 988
Claus B. Andersen Denmark 16 187 0.3× 74 0.2× 24 0.1× 23 0.1× 195 1.7× 27 909
M. Ohishi Japan 16 297 0.5× 97 0.2× 36 0.1× 8 0.1× 152 1.3× 25 804
Carmen A. Ambarus Netherlands 14 271 0.4× 140 0.3× 33 0.1× 15 0.1× 379 3.2× 28 1.1k
Jean Marc Durand France 10 124 0.2× 181 0.4× 14 0.0× 113 0.7× 351 3.0× 14 978

Countries citing papers authored by Stephen Adamu

Since Specialization
Citations

This map shows the geographic impact of Stephen Adamu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Adamu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Adamu more than expected).

Fields of papers citing papers by Stephen Adamu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Adamu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Adamu. The network helps show where Stephen Adamu may publish in the future.

Co-authorship network of co-authors of Stephen Adamu

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Adamu. A scholar is included among the top collaborators of Stephen Adamu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Adamu. Stephen Adamu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adamu, Stephen. (2017). Impact of corporate social responsibility on financial performance in the pharmaceutical industry. Pepperdine Digital Commons (Pepperdine University). 1 indexed citations
2.
Kostenuik, Paul J., Michael S. Ominsky, Sean Morony, et al.. (2007). Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease. Osteoporosis International. 19(5). 625–635. 25 indexed citations
3.
Li, Ji, Ildiko Sarosi, Russell C. Cattley, et al.. (2006). Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone. 39(4). 754–766. 348 indexed citations
4.
Stolina, Marina, Stephen Adamu, Denise Dwyer, et al.. (2005). RANKL is a Marker and Mediator of Local and Systemic Bone Loss in Two Rat Models of Inflammatory Arthritis. Journal of Bone and Mineral Research. 20(10). 1756–1765. 82 indexed citations
5.
Abrahamsen, Bo, Jacob Hjelmborg, Paul J. Kostenuik, et al.. (2005). Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins. Bone. 36(4). 727–735. 36 indexed citations
6.
Morony, Sean, Kelly Warmington, Stephen Adamu, et al.. (2005). The Inhibition of RANKL Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared with Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy. Endocrinology. 146(8). 3235–3243. 82 indexed citations
7.
Morony, Sean, Kelly Warmington, Stephen Adamu, et al.. (2005). The RANKL Inhibitor Osteoprotegerin (OPG) Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared to Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy. 11 indexed citations
8.
Capparelli, C., Sean Morony, Kelly Warmington, et al.. (2003). Sustained Antiresorptive Effects After a Single Treatment With Human Recombinant Osteoprotegerin (OPG): A Pharmacodynamic and Pharmacokinetic Analysis in Rats. Journal of Bone and Mineral Research. 18(5). 852–858. 85 indexed citations
9.
McCarthy, Timothy J., William A. Banks, Catherine L. Farrell, et al.. (2002). Positron Emission Tomography Shows that Intrathecal Leptin Reaches the Hypothalamus in Baboons. Journal of Pharmacology and Experimental Therapeutics. 301(3). 878–883. 22 indexed citations
10.
Kostenuik, Paul J., Casey Capparelli, Sean Morony, et al.. (2001). OPG and PTH-(1–34) Have Additive Effects on Bone Density and Mechanical Strength in Osteopenic Ovariectomized Rats. Endocrinology. 142(10). 4295–4304. 112 indexed citations
11.
Yoshizumi, Marc O., et al.. (1998). TIMING OF DEXAMETHASONE TREATMENT IN EXPERIMENTAL STAPHYLOCOCCUS AUREUS ENDOPHTHALMITIS. Retina. 18(2). 130–135. 29 indexed citations
12.
Giese, Michael J., et al.. (1996). The Effect of Staphylococcus aureus Phage Lysate Vaccine on a Rabbit Model of Staphylococcal Blepharitis, Phlyctenulosis, and Catarrhal Infiltrates. American Journal of Ophthalmology. 122(2). 245–254. 6 indexed citations
13.
Ravindranath, Rajeswari M.H., et al.. (1995). Immunopathologic features of Staphylococcus aureus endophthalmitis in the rat.. PubMed. 36(12). 2482–91. 14 indexed citations
14.
Giese, Michael J., et al.. (1994). Complement system and host defense against staphylococcal endophthalmitis.. PubMed. 35(3). 1026–32. 27 indexed citations
15.
Pleyer, Uwe, et al.. (1993). Collagen Shields Impregnated With Gentamicin-dexamethasone as a Potential Drug Delivery Device. American Journal of Ophthalmology. 116(5). 622–627. 24 indexed citations
16.
Pleyer, Uwe, et al.. (1992). Immune response to Staphylococcus epidermidis-induced endophthalmitis in a rabbit model.. PubMed. 33(9). 2650–63. 42 indexed citations
17.
Mondino, Bartly J., et al.. (1991). Immune response to Staphylococcus aureus endophthalmitis in a rabbit model.. PubMed. 32(5). 1523–33. 26 indexed citations
18.
Mondino, Bartly J., et al.. (1987). Ocular immunity to Staphylococcus aureus.. PubMed. 28(3). 560–4. 10 indexed citations
19.
Adamu, Stephen, et al.. (1987). Corneal antibody levels to ribitol teichoic acid in rabbits immunized with staphylococcal antigens using various routes.. PubMed. 28(9). 1553–8. 8 indexed citations
20.
Adamu, Stephen & J. F. Sperry. (1981). Polymorphonuclear neutrophil chemotaxis induced and inhibited by Bacteroides spp. Infection and Immunity. 33(3). 806–810. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026